PACS Group, Inc. Form 4 Filings

PACS Group, Inc. (PACS) director and ten percent owner Mark Hancock reported open-market sales of 300,000 shares of Common Stock on September 14–15, 2026. The sales occurred in multiple transactions at weighted-average prices ranging from about $41.47 to $45.13 per share, and were effected under a Rule 10b5-1 trading plan adopted on March 11, 2026.

PACS Group, Inc. (PACS) Co-Founder, CEO & Chairman and ten percent owner Murray Jason Hulse reported selling a total of 19,617 shares of common stock in three open-market transactions on September 10, 11 and 14, 2026, at weighted average prices around $45 per share.

Each transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on May 18, 2026, with prices disclosed as weighted averages over ranges between $45.00 and approximately $45.76 per share.

PACS Group, Inc. (PACS) disclosed that reporting person Murray Jason Hulse, its Co-Founder, CEO & Chairman and a ten percent owner, sold a total of 51,887 shares of common stock in several open-market or private transactions on September 4, 8 and 9, 2026 under a Rule 10b5-1 trading plan adopted on May 18, 2026. The reported per-share prices are weighted averages, with the underlying trades executed within disclosed price ranges around the low- to mid-$40s per share.

PACS Group, Inc. (PACS) reported that Co-Founder, CEO & Chairman and ten percent owner Murray Jason Hulse sold an aggregate 68,113 shares of common stock in six open-market transactions from September 1–3, 2026. Reported weighted-average prices for the sales ranged from about $41.92 to $43.78 per share, as detailed in transaction-specific ranges.

The transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on May 18, 2026, and all sales were reported as directly owned common stock. The filing does not state the number of shares Mr. Hulse continues to hold after these transactions.

PACS Group, Inc. (PACS) reported that director and ten percent owner Mark Hancock made a bona fide gift of 88,000 shares of Common Stock on 2026-08-18. The shares were given to a charitable donor-advised fund. Following this gift, Hancock directly holds 53,818,884 Common Stock shares.

PACS Group, Inc. (PACS) director Patrick Hugh Conway reported a sale of company common stock. On 2026-08-14, he sold 3,497 shares of Common Stock in a transaction described as a sale in an open market or private transaction at $44.41 per share. Following this transaction, he directly holds 8,947 shares of PACS Group, Inc. common stock.

PACS Group, Inc. (PACS) director and Co-Founder, CEO & Chairman Murray Jason Hulse reported open-market sales of an aggregate 150,550 shares of common stock on August 20–21, 2026, in multiple transactions at weighted average prices in the low-to-mid $40s per share, effected under a Rule 10b5-1 trading plan adopted on May 18, 2026.

PACS Group, Inc. (PACS) reported insider sales by Co-Founder, CEO & Chairman Murray Jason Hulse. Over August 17–19, 2026, he sold a total of 236,116 shares of common stock in open-market transactions under a Rule 10b5-1 trading plan adopted on May 18, 2026. Reported weighted-average prices ranged from about $42.81 to $44.86 per share, with detailed price breakdowns available on request to the company or the SEC staff.

PACS Group, Inc. executive Joshua Jergensen, President & COO, reported two open-market sales of 40,000 shares of common stock on August 12, 2026. The transactions, executed under a Rule 10b5-1 trading plan adopted on March 12, 2026, occurred at weighted average prices of $44.5299 and $45.6981 per share, each reflecting multiple trades within disclosed price ranges.

PACS Group, Inc. President & COO Joshua Jergensen reported three open-market sales totaling 40,000 shares of common stock on July 15, 2026. The shares were sold at weighted average prices between $43.74 and $45.78 per share under a Rule 10b5-1 trading plan adopted March 12, 2026. The transactions were reported as sales of stock held in his direct ownership, and he continues to hold PACS Group common stock afterward.

PACS Group, Inc. director and ten percent owner Mark Hancock reported open-market sales of 13,628 shares of common stock on July 14 and 15, 2026. The shares were sold at weighted average prices of $45.0350 and $45.0525 per share under a Rule 10b5-1 trading plan adopted on March 11, 2026. Following these transactions, Hancock directly holds 53,906,884 shares of PACS Group common stock.

PACS Group, Inc. director and ten-percent owner Mark Hancock reported open-market sales of common stock totaling 25,304 shares on July 8–9, 2026, at weighted average prices of about $45 per share. After these transactions, he directly holds more than 53.9 million shares of PACS Group common stock. The sales were effected pursuant to a Rule 10b5-1 trading plan and were executed in multiple trades within disclosed price ranges.

PACS Group, Inc. Chief Accounting Officer Michelle Renee Lewis reported selling a total of 15,000 shares of common stock in three open-market transactions at weighted average prices around $45 per share. These sales were made pursuant to a Rule 10b5-1 trading plan adopted on March 3, 2026, and she continues to hold 355,338 shares directly after the transactions.

PACS Group director and ten percent owner Mark Hancock reported a mix of stock sales and a new equity award. On July 6, 2026, he sold 142,163 shares of common stock at a weighted average price of $45.3343 per share. He also sold 12,825 shares on July 2, 2026 at $45.0129 and 6,080 shares on July 1, 2026 at $45.0191, all as open-market transactions under a pre-arranged Rule 10b5-1 trading plan.

Following these trades, Hancock directly held 53,945,816 shares of PACS Group common stock. Separately, on July 1, 2026 he received 4,287 restricted stock units, each convertible into one share of common stock, vesting 100% on the earlier of July 1, 2027 or the next annual meeting, subject to his continued service.

PACS Group, Inc. director Patrick Hugh Conway reported receiving an equity award in the form of 4,287 restricted stock units of Common Stock. These RSUs carry no purchase price and increase his direct holdings to 12,444 shares after the award.

The footnote explains that each RSU will convert into one share of Common Stock upon vesting. All RSUs vest on the earlier of July 1, 2027 or the company’s next annual meeting after the grant date, as long as Conway continues to serve the company through that time.

PACS Group, Inc. director Jacqueline Millard received an equity grant in the form of restricted stock units. She acquired 4,287 RSUs, each convertible into one share of common stock upon vesting, at no cash purchase price. After this grant, she holds 20,217 shares of common stock directly. The RSUs will vest 100% on the earlier of July 1, 2027 or the next annual meeting following the grant date, if she continues serving the company.

PACS Group, Inc. reported that director Taylor S. Leavitt received a grant of 4,287 restricted stock units (RSUs), with no cash paid per share. Each RSU will convert into one share of common stock when it vests.

According to the terms, 100% of the RSUs vest on the earlier of July 1, 2027 or the date of the next annual meeting following the grant, as long as Leavitt continues serving the company. After this award, Leavitt holds 19,784 shares of common stock directly.

Dilsaver Evelyn S reported acquisition or exercise transactions in this Form 4 filing.

PACS Group, Inc. director Evelyn S. Dilsaver received an equity award in the form of 4,287 shares of Common Stock as a grant, reported at a price of $0.00 per share, indicating compensation rather than a market purchase. This award is structured as restricted stock units (RSUs), each convertible into one share of Common Stock upon vesting. All of the RSUs will vest on the earlier of July 1, 2027 or the date of the next annual meeting following the grant, assuming she continues to serve the company. After this grant, her directly held position reported in this filing is 36,085 shares of Common Stock.

PACS Group, Inc. director and executive vice chair Mark Hancock reported open-market sales of a total of 200,000 shares of common stock. The trades occurred on June 25 and 26, 2026 at weighted average prices around $40–$41 per share.

The filing shows Hancock continues to hold more than 54 million shares of PACS Group common stock directly after these transactions. According to a footnote, the June 2026 sales were effected under a pre‑arranged Rule 10b5-1 trading plan adopted on March 11, 2026, indicating they were scheduled in advance rather than timed discretionarily.

PACS Group, Inc. Chief Accounting Officer Michelle Renee Lewis sold 15,000 shares of common stock in an open-market transaction at a weighted average price of about $40.0119 per share. The sale was executed under a pre-arranged Rule 10b5-1 trading plan, and she continues to hold 370,338 shares directly.

PACS Group, Inc. director and executive vice chair Mark Hancock reported two open-market sales of common stock on June 17, 2026 totaling 63,680 shares. The shares were sold at weighted average prices of $35.2838 and $35.7491 per share under a pre-arranged Rule 10b5-1 trading plan adopted on March 11, 2026. After these transactions, Hancock directly holds about 54.3 million shares of PACS Group common stock.

PACS Group, Inc. director and co-founder Mark Hancock reported open-market sales of company common stock. Across four transactions on June 15–16, 2026, he sold a total of 236,320 shares, including 83,066 shares at a weighted average price of $35.9038 per share and 134,093 shares at $36.2341 per share.

The filing states these sales were carried out under a pre-arranged Rule 10b5-1 trading plan adopted on March 11, 2026, indicating they were scheduled in advance. After these transactions, Hancock directly owned 54,366,277 shares of PACS Group common stock.

PACS Group, Inc. director Patrick Hugh Conway received a grant of 4,660 restricted stock units (RSUs) of Common Stock. These RSUs convert into one share each upon vesting, giving him 8,157 shares in total after the award. All RSUs vest 100% on the earlier of June 10, 2027 or the next annual meeting following the grant date, as long as he continues serving the company.

LEAVITT TAYLOR S. reported acquisition or exercise transactions in this Form 4 filing.

PACS Group, Inc. director Taylor S. Leavitt received an equity grant of 4,660 restricted stock units (RSUs), each convertible into one share of common stock upon vesting. After this award, Leavitt holds 15,497 shares of common stock directly.

The RSUs will vest 100% on the earlier of June 10, 2027 or the date of the next annual meeting following the grant, as long as Leavitt continues to serve the company. This filing reflects a compensation-related share award rather than an open-market purchase or sale.

PACS Group, Inc. director Jacqueline Millard reported a stock-based compensation award. She acquired 4,660 shares of Common Stock in the form of restricted stock units (RSUs) granted at no cash cost, increasing her direct holdings to 15,930 shares after the transaction.

The RSUs entitle her to one share of Common Stock for each unit when they vest. All 4,660 RSUs will vest on the earlier of June 10, 2027 or the next annual meeting following the grant date, as long as she continues to serve the company.

PACS Group, Inc. director Evelyn S. Dilsaver received a grant of 4,660 restricted stock units (RSUs) of Common Stock. The award was granted at no cash price per share as equity compensation.

Each RSU converts into one share upon vesting, and 100% of the RSUs will vest on the earlier of June 10, 2027 or the next annual meeting following the grant date, subject to her continued service. Following this grant, she directly holds 31,798 shares.

PACS Group, Inc. Chief Legal Officer & Secretary John Todd Mitchell sold 80,152 shares of common stock in open-market transactions. The sales occurred on May 15 and May 18, 2026 at weighted average prices in the high-$30 range under a pre-arranged Rule 10b5-1 trading plan adopted on December 8, 2025. Following these trades, he continues to hold more than 800,000 PACS shares directly.

HENDRICKSON CAREY P reported acquisition or exercise transactions in this Form 4 filing.

PACS Group, Inc. reported that Chief Financial Officer Carey P. Hendrickson received a grant of 48,426 restricted stock units (RSUs) of Common Stock. The RSUs were awarded at no cash cost and will vest in three substantially equal annual installments on the first, second, and third anniversaries of May 14, 2026, subject to his continued service. Following this grant, he directly holds 48,426 RSUs representing an equivalent number of Common Stock shares upon vesting.

PACS Group, Inc. Chief Accounting Officer Michelle Renee Lewis reported a routine tax-withholding transaction related to equity compensation. On the vesting of previously granted restricted stock units, 24,691 shares of common stock were withheld at $33.14 per share to cover tax liabilities, rather than sold in the open market. After this withholding, Lewis directly holds 385,338 shares of PACS Group common stock, indicating she retains a substantial equity position following the compensation-related event.

PACS Group, Inc. Chief Legal Officer and Secretary John Todd Mitchell reported a routine tax-related share disposition. On the reported date, 66,471 shares of common stock were withheld at a value of $33.14 per share to cover tax liabilities tied to vesting restricted stock units. After this withholding, he directly held 883,718 shares of PACS Group common stock, indicating he retained a substantial equity position.

PACS Group, Inc. President & COO Joshua Jergensen reported a tax-withholding disposition related to equity compensation. On the vesting of previously granted restricted stock units, 197,525 shares of common stock were withheld at $33.14 per share to cover tax liabilities. After this non-market transaction, Jergensen directly holds 2,616,320 shares of PACS Group common stock, indicating this was a routine compensation-related tax event rather than an open-market sale.

Priegnitz Kelly reported acquisition or exercise transactions in this Form 4 filing.

PACS Group, Inc. reported that Chief Compliance Officer Kelly Priegnitz received a grant of 8,203 restricted stock units of common stock. These RSUs vest in three substantially equal annual installments starting on March 24, 2026, and will deliver one share per unit at vesting. Following this award, Priegnitz directly holds 38,203 shares of common stock.

PACS Group, Inc. Chief Human Resources Officer Trent Dean Bingham reported an equity compensation grant on Common Stock. He acquired 14,649 restricted stock units (RSUs) for no cash payment, increasing his directly held equity-related position to 39,649 shares/units reported after the transaction.

The RSUs convert into one share of Common Stock each upon vesting. They are scheduled to vest in substantially equal annual installments on the first, second, and third anniversaries of March 24, 2026, contingent on his continued service through each vesting date.

Lewis Michelle Renee reported acquisition or exercise transactions in this Form 4 filing.

PACS Group, Inc. reported that Chief Accounting Officer Michelle Renee Lewis received a grant of 35,159 restricted stock units (RSUs) of Common Stock. Each RSU represents the right to receive one share upon vesting. Following this equity award, she now holds 410,029 shares directly, including these RSUs.

The RSUs will vest in substantially equal annual installments on the first, second, and third anniversaries of March 24, 2026, and vesting is conditioned on her continued service with the company through each vesting date.

MITCHELL JOHN TODD reported acquisition or exercise transactions in this Form 4 filing.

PACS Group, Inc. reported that Chief Legal Officer and Secretary John Todd Mitchell received a grant of 82,039 shares of Common Stock in the form of restricted stock units. These RSUs vest in three substantially equal annual installments starting on the first anniversary of March 24, 2026, contingent on his continued service. Following this award, he directly holds 950,189 shares of the company’s Common Stock, reflecting a significant ongoing equity stake aligned with long-term performance.

Jergensen Joshua reported acquisition or exercise transactions in this Form 4 filing.

PACS Group, Inc. reported that President & COO Joshua Jergensen received an award of 146,498 restricted stock units (RSUs) of Common Stock. After this grant, he holds 2,813,845 shares directly. The RSUs vest in substantially equal annual installments on the first, second, and third anniversaries of March 24, 2026, subject to his continued service.

PACS Group, Inc. director and officer Mark Hancock received an equity award in the form of 98,154 restricted stock units (RSUs) of Common Stock. Each RSU converts into one share upon vesting and the award was reported at a price of $0.00 per share, indicating a compensation grant rather than a market purchase.

The RSUs vest in substantially equal annual installments on the first, second, and third anniversaries of March 24, 2026, conditioned on Hancock’s continued service. Following this grant, Hancock directly holds 54,602,597 shares of Common Stock, making the award relatively small compared with his overall reported holdings.

PACS Group, Inc. director and Co-Founder, CEO & Chairman Murray Jason Hulse reported an equity compensation award in the form of restricted stock units. He received 234,397 RSUs of Common Stock at a grant price of $0.00 per share, classified as a grant or award acquisition. These RSUs will vest in substantially equal annual installments on the first, second, and third anniversaries of March 24, 2026, subject to his continued service. Following this grant, his directly held Common Stock position reported in this filing is 55,081,532 shares.

PACS Group, Inc. President & COO Joshua Jergensen reported an open-market sale of common stock. On March 13, 2026, he sold 36,335 shares of PACS Group common stock at a weighted average price of $34.2823 per share.

The shares were sold in multiple trades at prices ranging from $34.28 to $34.3301 per share, according to the footnote. After these transactions, Jergensen directly owns 2,667,347 shares of PACS Group common stock.

PACS Group, Inc. director and executive officer Mark Hancock reported a bona fide gift transfer of 300,000 shares of common stock on March 5, 2026. The shares were gifted to a charitable donor-advised fund and carried a reported price of $0.00 per share. After this disposition, Hancock directly owned 54,504,443 shares of PACS Group common stock.

PACS Group, Inc. reported that director Patrick Hugh Conway acquired 3,497 restricted stock units (RSUs) of Common Stock as a grant. Each RSU represents the right to receive one share of Common Stock upon vesting. According to the terms, 100% of the RSUs will vest on the earlier of March 4, 2027 or the next annual meeting following the grant date, subject to his continued service to the company.

PACS Group, Inc. reported that Chief Compliance Officer Kelly Priegnitz received an award of 30,000 shares of common stock in the form of restricted stock units. Each RSU converts into one share upon vesting. The RSUs vest in substantially equal annual installments on the first, second, and third anniversaries of December 1, 2025, contingent on continued service.

PACS Group, Inc. reported that Chief Human Resources Officer Trent Dean Bingham received a grant of 25,000 shares of Common Stock in the form of restricted stock units. Each RSU converts into one share upon vesting, in substantially equal annual installments on the first, second, and third anniversaries of November 10, 2025, contingent on continued service.

PACS Group, Inc. Chief Accounting Officer reports tax withholding share transaction. Michelle Renee Lewis reported that on 01/15/2026, 3,348 shares of PACS Group, Inc. common stock were withheld at a price of $39.49 per share. The filing explains this was a payment of tax liability through the withholding of shares upon the vesting of previously granted and reported restricted stock units. After this transaction, Lewis beneficially owned 374,870 shares of PACS Group, Inc. common stock, held directly.

PACS Group, Inc. Chief Legal Officer and Secretary John Todd Mitchell reported a Form 4 transaction involving company common stock. On 01/15/2026, 9,541 shares of PACS Group common stock were withheld at a price of $39.49 per share. According to the footnote, this was a payment of tax liability through the withholding of shares upon the vesting of previously granted and reported restricted stock units, rather than an open-market sale. Following this tax withholding, Mitchell directly beneficially owned 868,150 shares of PACS Group common stock.

PACS Group, Inc. President & COO Joshua Jergensen reported a routine tax-withholding transaction in company common stock. On January 15, 2026, 21,998 shares of PACS Group common stock were withheld at a reference price of $39.49 per share, coded as an "F" transaction, which the disclosure explains was to pay tax liabilities arising from the vesting of previously granted restricted stock units.

Following this withholding, Jergensen beneficially owns 2,703,682 shares of PACS Group common stock, held directly. This filing reflects administrative share withholding for taxes rather than an open-market sale.

PACS Group, Inc. reported an insider equity transaction by Mark Hancock, a director, co-founder, interim CFO, executive vice chair, and 10% owner. On January 15, 2026, 12,774 shares of common stock were withheld at $39.49 per share to satisfy tax liabilities arising from the vesting of previously granted and reported restricted stock units. This was recorded as a disposition under code F, which denotes tax withholding rather than an open-market sale. Following this transaction, Hancock beneficially owns 54,804,443 shares of PACS Group common stock in direct ownership.

PACS Group, Inc. insider activity: Co-Founder, CEO and Chairman Murray Jason Hulse reported a tax-related share withholding tied to vested restricted stock units. On 01/15/2026, 20,082 shares of common stock were withheld at a price of $39.49 per share to satisfy tax liabilities upon vesting of previously granted and reported restricted stock units, as described in the footnote. After this transaction, Hulse beneficially owned 54,847,135 shares of PACS Group common stock in direct form.

PACS Group, Inc. reported that one of its directors received a grant of restricted stock units on December 19, 2025. The grant covers 4,399 RSUs, each representing the right to receive one share of PACS Group common stock when it vests, at a grant price of $0 per unit.

After this award, the director beneficially owns 10,837 shares of common stock in total. The RSUs will vest 100% on the earlier of December 19, 2026 or the date of the next annual meeting following the grant, as long as the director continues to serve the company.